AN2 Therapeutics

Biopharma flotations tank in the first quarter
EP Vantage
Thu, 04/7/22 - 10:11 am
Amylyx Pharmaceuticals
CinCor Pharma
Arcellx
Vigil Neuroscience
AN2 Therapeutics
IPOs
Another RA-backed biotech hits Nasdaq as public market stirs again after a bruising first quarter
Endpoints
Fri, 03/25/22 - 10:29 am
AN2 Therapeutics
lung disease
funding
RA Capital
venture capital
IPOs
With lung drug from Pfizer in hand, AN2 tests IPO waters in turbulent market
MedCity News
Tue, 03/8/22 - 10:01 am
AN2 Therapeutics
Okyo Pharma
IPOs
clinical trials
lung disease
dry eye disease
Brii bags rights to tuberculosis drug to further antibiotic push
Fierce Biotech
Thu, 11/21/19 - 10:25 am
Brii Biosciences
China
AN2 Therapeutics
tuberculosis
antibiotics